Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fuchs

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Environmental Research and Public Health|April 3, 2021
The Summer 2019-2020 Wildfires in East Coast Australia and Their Impacts on Air Quality and Health in New South Wales, AustraliaHiep Duc Nguyen, Merched Azzi, Stephen White, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondiiMarkus M Heimesaat, Stefan Bereswill, André Fischer, et al.
BMC Cancer|November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Plos One|July 27, 2007
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4Markus M Heimesaat, André Fischer, Britta Siegmund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast CancerChristian F Singer, Yen Y Tan, Florian Fitzal, et al.
The Journal of Investigative Dermatology|February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on MastocytosisElisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Alex Kilbertus, Karin Kofler, et al.
Allergy|February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
Leukemia|November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryHanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Environmental Research and Public Health|April 3, 2021
The Summer 2019-2020 Wildfires in East Coast Australia and Their Impacts on Air Quality and Health in New South Wales, AustraliaHiep Duc Nguyen, Merched Azzi, Stephen White, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondiiMarkus M Heimesaat, Stefan Bereswill, André Fischer, et al.
BMC Cancer|November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Plos One|July 27, 2007
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4Markus M Heimesaat, André Fischer, Britta Siegmund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast CancerChristian F Singer, Yen Y Tan, Florian Fitzal, et al.
The Journal of Investigative Dermatology|February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on MastocytosisElisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the SkinDavid Fuchs, Alex Kilbertus, Karin Kofler, et al.
Allergy|February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
Leukemia|November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryHanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Pageof 5